197 related articles for article (PubMed ID: 25001513)
1. Advances in transient receptor potential vanilloid-2 channel expression and function in tumor growth and progression.
Liberati S; Morelli MB; Amantini C; Santoni M; Nabissi M; Cardinali C; Santoni G
Curr Protein Pept Sci; 2014; 15(7):732-7. PubMed ID: 25001513
[TBL] [Abstract][Full Text] [Related]
2. Role of cationic channel TRPV2 in promoting prostate cancer migration and progression to androgen resistance.
Monet M; Lehen'kyi V; Gackiere F; Firlej V; Vandenberghe M; Roudbaraki M; Gkika D; Pourtier A; Bidaux G; Slomianny C; Delcourt P; Rassendren F; Bergerat JP; Ceraline J; Cabon F; Humez S; Prevarskaya N
Cancer Res; 2010 Feb; 70(3):1225-35. PubMed ID: 20103638
[TBL] [Abstract][Full Text] [Related]
3. TRPV2: A Cancer Biomarker and Potential Therapeutic Target.
Siveen KS; Nizamuddin PB; Uddin S; Al-Thani M; Frenneaux MP; Janahi IA; Steinhoff M; Azizi F
Dis Markers; 2020; 2020():8892312. PubMed ID: 33376561
[TBL] [Abstract][Full Text] [Related]
4. The TRPV2 cation channels: from urothelial cancer invasiveness to glioblastoma multiforme interactome signature.
Santoni G; Amantini C; Maggi F; Marinelli O; Santoni M; Nabissi M; Morelli MB
Lab Invest; 2020 Feb; 100(2):186-198. PubMed ID: 31653969
[TBL] [Abstract][Full Text] [Related]
5. TRPV2.
Kojima I; Nagasawa M
Handb Exp Pharmacol; 2014; 222():247-72. PubMed ID: 24756709
[TBL] [Abstract][Full Text] [Related]
6. TRPV2 Promotes Cell Migration and Invasion in Gastric Cancer via the Transforming Growth Factor-β Signaling Pathway.
Kato S; Shiozaki A; Kudou M; Shimizu H; Kosuga T; Ohashi T; Arita T; Konishi H; Komatsu S; Kubota T; Fujiwara H; Okamoto K; Kishimoto M; Konishi E; Otsuji E
Ann Surg Oncol; 2022 May; 29(5):2944-2956. PubMed ID: 34855064
[TBL] [Abstract][Full Text] [Related]
7. The transient receptor potential vanilloid-2 cation channel impairs glioblastoma stem-like cell proliferation and promotes differentiation.
Morelli MB; Nabissi M; Amantini C; Farfariello V; Ricci-Vitiani L; di Martino S; Pallini R; Larocca LM; Caprodossi S; Santoni M; De Maria R; Santoni G
Int J Cancer; 2012 Oct; 131(7):E1067-77. PubMed ID: 22492283
[TBL] [Abstract][Full Text] [Related]
8. Expression and distribution of three transient receptor potential vanilloid(TRPV) channel proteins in human odontoblast-like cells.
Wen W; Que K; Zang C; Wen J; Sun G; Zhao Z; Li Y
J Mol Histol; 2017 Dec; 48(5-6):367-377. PubMed ID: 28905239
[TBL] [Abstract][Full Text] [Related]
9. The Effects of Cannabidiol and Prognostic Role of TRPV2 in Human Endometrial Cancer.
Marinelli O; Morelli MB; Annibali D; Aguzzi C; Zeppa L; Tuyaerts S; Amantini C; Amant F; Ferretti B; Maggi F; Santoni G; Nabissi M
Int J Mol Sci; 2020 Jul; 21(15):. PubMed ID: 32751388
[TBL] [Abstract][Full Text] [Related]
10. Loss of TRPV2 Homeostatic Control of Cell Proliferation Drives Tumor Progression.
Liberati S; Morelli MB; Amantini C; Farfariello V; Santoni M; Conti A; Nabissi M; Cascinu S; Santoni G
Cells; 2014 Feb; 3(1):112-28. PubMed ID: 24709905
[TBL] [Abstract][Full Text] [Related]
11. Transient receptor potential vanilloid type 2 (TRPV2) expression in normal urothelium and in urothelial carcinoma of human bladder: correlation with the pathologic stage.
Caprodossi S; Lucciarini R; Amantini C; Nabissi M; Canesin G; Ballarini P; Di Spilimbergo A; Cardarelli MA; Servi L; Mammana G; Santoni G
Eur Urol; 2008 Sep; 54(3):612-20. PubMed ID: 17977643
[TBL] [Abstract][Full Text] [Related]
12. Esophageal cancer stem cells are suppressed by tranilast, a TRPV2 channel inhibitor.
Shiozaki A; Kudou M; Ichikawa D; Fujiwara H; Shimizu H; Ishimoto T; Arita T; Kosuga T; Konishi H; Komatsu S; Okamoto K; Marunaka Y; Otsuji E
J Gastroenterol; 2018 Feb; 53(2):197-207. PubMed ID: 28389731
[TBL] [Abstract][Full Text] [Related]
13. TRPV2 mediates adrenomedullin stimulation of prostate and urothelial cancer cell adhesion, migration and invasion.
Oulidi A; Bokhobza A; Gkika D; Vanden Abeele F; Lehen'kyi V; Ouafik L; Mauroy B; Prevarskaya N
PLoS One; 2013; 8(5):e64885. PubMed ID: 23741410
[TBL] [Abstract][Full Text] [Related]
14. Transient receptor potential vanilloid 2 activation by focal mechanical stimulation requires interaction with the actin cytoskeleton and enhances growth cone motility.
Sugio S; Nagasawa M; Kojima I; Ishizaki Y; Shibasaki K
FASEB J; 2017 Apr; 31(4):1368-1381. PubMed ID: 28007781
[TBL] [Abstract][Full Text] [Related]
15. Functional TRPV2 and TRPV4 channels in human cardiac c-kit(+) progenitor cells.
Che H; Xiao GS; Sun HY; Wang Y; Li GR
J Cell Mol Med; 2016 Jun; 20(6):1118-27. PubMed ID: 26865051
[TBL] [Abstract][Full Text] [Related]
16. Transient receptor potential vanilloid-type 2 targeting on stemness in liver cancer.
Hu Z; Cao X; Fang Y; Liu G; Xie C; Qian K; Lei X; Cao Z; Du H; Cheng X; Xu X
Biomed Pharmacother; 2018 Sep; 105():697-706. PubMed ID: 29906748
[TBL] [Abstract][Full Text] [Related]
17. PI3-kinase promotes TRPV2 activity independently of channel translocation to the plasma membrane.
Penna A; Juvin V; Chemin J; Compan V; Monet M; Rassendren FA
Cell Calcium; 2006 Jun; 39(6):495-507. PubMed ID: 16533525
[TBL] [Abstract][Full Text] [Related]
18. Potential role of transient receptor potential (TRP) channels in bladder cancer cells.
Mizuno H; Suzuki Y; Watanabe M; Sokabe T; Yamamoto T; Hattori R; Gotoh M; Tominaga M
J Physiol Sci; 2014 Jul; 64(4):305-14. PubMed ID: 24849279
[TBL] [Abstract][Full Text] [Related]
19. The mechanosensitive TRPV2 calcium channel promotes human melanoma invasiveness and metastatic potential.
Shoji KF; Bayet E; Leverrier-Penna S; Le Devedec D; Mallavialle A; Marionneau-Lambot S; Rambow F; Perret R; Joussaume A; Viel R; Fautrel A; Khammari A; Constantin B; Tartare-Deckert S; Penna A
EMBO Rep; 2023 Apr; 24(4):e55069. PubMed ID: 36744297
[TBL] [Abstract][Full Text] [Related]
20. The effects of cannabidiol and its synergism with bortezomib in multiple myeloma cell lines. A role for transient receptor potential vanilloid type-2.
Morelli MB; Offidani M; Alesiani F; Discepoli G; Liberati S; Olivieri A; Santoni M; Santoni G; Leoni P; Nabissi M
Int J Cancer; 2014 Jun; 134(11):2534-46. PubMed ID: 24293211
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
